Brooklyn Stock Probability of Future Stock Price Finishing Under 0.32

BTX
 Stock
  

USD 3.30  0.08  2.48%   

Brooklyn ImmunoTherapeuti's future price is the expected price of Brooklyn ImmunoTherapeuti instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Brooklyn ImmunoTherapeutics In performance during a given time horizon utilizing its historical volatility.
  
Brooklyn ImmunoTherapeuti's implied volatility is one of the determining factors in the pricing options written on Brooklyn ImmunoTherapeutics In. Implied volatility approximates the future value of Brooklyn ImmunoTherapeuti based on the option's current value. Options with high implied volatility have higher premiums and can be used to hedge the downside of investing in Brooklyn ImmunoTherapeutics In over a specific time period. For example, 2023-01-20 PUT at $12.5 is a PUT option contract on Brooklyn ImmunoTherapeuti's common stock with a strick price of 12.5 expiring on 2023-01-20. The contract was last traded on 2022-02-17 at 09:47:02 for $10.0 and, as of today, has 51 days remaining before the expiration. The option is currently trading at a bid price of $8.2, and an ask price of $13.0. The implied volatility as of the 30th of November is 452.0489. View All Brooklyn options

Closest to current price Brooklyn long PUT Option Payoff at Expiration

Continue to Brooklyn ImmunoTherapeuti Backtesting, Brooklyn ImmunoTherapeuti Valuation, Brooklyn ImmunoTherapeuti Correlation, Brooklyn ImmunoTherapeuti Hype Analysis, Brooklyn ImmunoTherapeuti Volatility, Brooklyn ImmunoTherapeuti History as well as Brooklyn ImmunoTherapeuti Performance. Please specify Brooklyn ImmunoTherapeuti time horizon, a valid symbol (red box) and a target price (blue box) you would like Brooklyn ImmunoTherapeuti odds to be computed.

Brooklyn ImmunoTherapeuti Target Price Odds to finish below 0.32

The tendency of Brooklyn Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to drop to $ 0.32  or more in 90 days
 3.30 90 days 0.32 
near 1
Based on a normal probability distribution, the odds of Brooklyn ImmunoTherapeuti to drop to $ 0.32  or more in 90 days from now is near 1 (This Brooklyn ImmunoTherapeutics In probability density function shows the probability of Brooklyn Stock to fall within a particular range of prices over 90 days) . Probability of Brooklyn ImmunoTherapeuti price to stay between $ 0.32  and its current price of $3.3 at the end of the 90-day period is about 17.13 .
Considering the 90-day investment horizon Brooklyn ImmunoTherapeutics In has a beta of -1.22 suggesting as returns on its benchmark rise, returns on holding Brooklyn ImmunoTherapeutics In are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Brooklyn ImmunoTherapeuti is expected to outperform its benchmark. Additionally The company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Brooklyn ImmunoTherapeuti is significantly underperforming DOW.
   Brooklyn ImmunoTherapeuti Price Density   
       Price  

Predictive Modules for Brooklyn ImmunoTherapeuti

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Brooklyn ImmunoTherapeuti. Regardless of method or technology, however, to accurately forecast the stock or bond market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Brooklyn ImmunoTherapeuti's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Brooklyn ImmunoTherapeuti in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.173.3010.02
Details
Intrinsic
Valuation
LowReal ValueHigh
0.306.0712.79
Details
Naive
Forecast
LowNext ValueHigh
0.073.7410.46
Details
2 Analysts
Consensus
LowTarget PriceHigh
9.0014.5020.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Brooklyn ImmunoTherapeuti. Your research has to be compared to or analyzed against Brooklyn ImmunoTherapeuti's peers to derive any actionable benefits. When done correctly, Brooklyn ImmunoTherapeuti's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Brooklyn ImmunoTherapeuti.

Brooklyn ImmunoTherapeuti Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Brooklyn ImmunoTherapeuti is not an exception. The market had few large corrections towards the Brooklyn ImmunoTherapeuti's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Brooklyn ImmunoTherapeutics In, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Brooklyn ImmunoTherapeuti within the framework of very fundamental risk indicators.
α
Alpha over DOW
-1.3
β
Beta against DOW-1.22
σ
Overall volatility
1.76
Ir
Information ratio -0.22

Brooklyn ImmunoTherapeuti Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Brooklyn ImmunoTherapeuti for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Brooklyn ImmunoTherapeuti can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Brooklyn ImmunoTherapeuti generated a negative expected return over the last 90 days
Brooklyn ImmunoTherapeuti has high historical volatility and very poor performance
Brooklyn ImmunoTherapeuti has high likelihood to experience some financial distress in the next 2 years
The company reported the last year's revenue of 3.45 M. Reported Net Loss for the year was (106.73 M) with profit before taxes, overhead, and interest of 4.69 M.
Brooklyn ImmunoTherapeutics In has about 19.41 M in cash with (22.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.33.
Roughly 42.0% of the company shares are held by company insiders

Brooklyn ImmunoTherapeuti Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Brooklyn Stock often depends not only on the future outlook of the current and potential Brooklyn ImmunoTherapeuti's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Brooklyn ImmunoTherapeuti's indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out1.74%
Short Percent Of Float2.18%
Float Shares34.05M
Shares Short Prior Month1.92M
Average Daily Volume Last 10 Day394.94k
Average Daily Volume In Three Month85.42k
Date Short Interest15th of September 2022

Brooklyn ImmunoTherapeuti Technical Analysis

Brooklyn ImmunoTherapeuti's future price can be derived by breaking down and analyzing its technical indicators over time. Brooklyn Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Brooklyn ImmunoTherapeutics In. In general, you should focus on analyzing Brooklyn Stock price patterns and their correlations with different microeconomic environments and drivers.

Brooklyn ImmunoTherapeuti Predictive Forecast Models

Brooklyn ImmunoTherapeuti time-series forecasting models is one of many Brooklyn ImmunoTherapeuti's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Brooklyn ImmunoTherapeuti's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Brooklyn ImmunoTherapeuti

Checking the ongoing alerts about Brooklyn ImmunoTherapeuti for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Brooklyn ImmunoTherapeuti help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Brooklyn ImmunoTherapeuti generated a negative expected return over the last 90 days
Brooklyn ImmunoTherapeuti has high historical volatility and very poor performance
Brooklyn ImmunoTherapeuti has high likelihood to experience some financial distress in the next 2 years
The company reported the last year's revenue of 3.45 M. Reported Net Loss for the year was (106.73 M) with profit before taxes, overhead, and interest of 4.69 M.
Brooklyn ImmunoTherapeutics In has about 19.41 M in cash with (22.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.33.
Roughly 42.0% of the company shares are held by company insiders
Continue to Brooklyn ImmunoTherapeuti Backtesting, Brooklyn ImmunoTherapeuti Valuation, Brooklyn ImmunoTherapeuti Correlation, Brooklyn ImmunoTherapeuti Hype Analysis, Brooklyn ImmunoTherapeuti Volatility, Brooklyn ImmunoTherapeuti History as well as Brooklyn ImmunoTherapeuti Performance. You can also try Watchlist Optimization module to optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm.

Complementary Tools for analysis

When running Brooklyn ImmunoTherapeuti price analysis, check to measure Brooklyn ImmunoTherapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brooklyn ImmunoTherapeuti is operating at the current time. Most of Brooklyn ImmunoTherapeuti's value examination focuses on studying past and present price action to predict the probability of Brooklyn ImmunoTherapeuti's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Brooklyn ImmunoTherapeuti's price. Additionally, you may evaluate how the addition of Brooklyn ImmunoTherapeuti to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Is Brooklyn ImmunoTherapeuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Brooklyn ImmunoTherapeuti. If investors know Brooklyn will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Brooklyn ImmunoTherapeuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
12 M
Return On Assets
(0.35) 
Return On Equity
(4.27) 
The market value of Brooklyn ImmunoTherapeuti is measured differently than its book value, which is the value of Brooklyn that is recorded on the company's balance sheet. Investors also form their own opinion of Brooklyn ImmunoTherapeuti's value that differs from its market value or its book value, called intrinsic value, which is Brooklyn ImmunoTherapeuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Brooklyn ImmunoTherapeuti's market value can be influenced by many factors that don't directly affect Brooklyn ImmunoTherapeuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Brooklyn ImmunoTherapeuti's value and its price as these two are different measures arrived at by different means. Investors typically determine Brooklyn ImmunoTherapeuti value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brooklyn ImmunoTherapeuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.